{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:51:45Z","timestamp":1775231505017,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1124\/mol.107.035998","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T00:49:08Z","timestamp":1175734148000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Nigrostriatal Damage Preferentially Decreases a Subpopulation of \u03b16\u03b22* nAChRs in Mouse, Monkey, and Parkinson\u2019s Disease Striatum"],"prefix":"10.1016","volume":"72","author":[{"given":"Tanuja","family":"Bordia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon R.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryka","family":"Quik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.035998_REF1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/jpet.104.071456","article-title":"Effect of novel \u03b1-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes","volume":"312","author":"Azam","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035998_REF2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.expneurol.2004.10.004","article-title":"Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [125I]alpha-conotoxinMII in the striatum and thalamus","volume":"191","author":"Bohr","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.035998_REF3","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knockout mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/BF02138873","article-title":"l-DOPA treatment in Parkinson\u2019s disease: effect on dopamine and related substances in discrete brain regions","volume":"27","author":"Davidson","year":"1971","journal-title":"Experientia"},{"key":"10.1124\/mol.107.035998_REF5","series-title":"A Stereotaxic Atlas of the Brain of the Squirrel Monkey (Saimiri sciureus)","author":"Emmers","year":"1963"},{"key":"10.1124\/mol.107.035998_REF6","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1523\/JNEUROSCI.07-12-03935.1987","article-title":"The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF7","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic: II. Patchand matrix-directed mesostriatal dopaminergic and non-dopaminergic systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb24523.x","article-title":"Midbrain dopaminergic cell loss in Parkinson\u2019s disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells","volume":"648","author":"German","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/mol.107.035998_REF9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1124\/mol.107.035998_REF10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2006.04.005","article-title":"Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer\u2019s disease, Parkinson\u2019s disease and dementia with Lewy bodies by immunoprecipitation","volume":"23","author":"Gotti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/mol.107.035998_REF11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138161206775474486","article-title":"Brain neuronal nicotinic receptors as new targets for drug discovery","volume":"12","author":"Gotti","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1124\/mol.107.035998_REF12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.107.035998_REF13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0306-4522(93)90349-K","article-title":"Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?","volume":"56","author":"Herrero","year":"1993","journal-title":"Neuroscience"},{"key":"10.1124\/mol.107.035998_REF14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1124\/mol.107.035998_REF15","first-page":"13","article-title":"Brain monoamines and parkinsonism","volume":"3","author":"Hornykiewicz","year":"1975","journal-title":"Natl Inst Drug Abuse Res Monogr Ser"},{"key":"10.1124\/mol.107.035998_REF16","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/mol.107.035998_REF17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1471-4159.2002.00868.x","article-title":"5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes","volume":"81","author":"Kulak","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.035998_REF19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(89)91114-1","article-title":"Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum","volume":"498","author":"Langer","year":"1989","journal-title":"Brain Res"},{"key":"10.1124\/mol.107.035998_REF20","first-page":"S79","article-title":"Investigating levodopa-induced dyskinesias in the parkinsonian primate","volume":"47","author":"Langston","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.107.035998_REF21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/neur.1996.0042","article-title":"Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration","volume":"5","author":"Liang","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1124\/mol.107.035998_REF22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.20036","article-title":"Aging of the nigrostriatal system in the squirrel monkey","volume":"471","author":"McCormack","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.107.035998_REF23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/mol.65.4.944","article-title":"Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors","volume":"65","author":"McIntosh","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.med.55.091902.104422","article-title":"The scientific basis for the current treatment of Parkinson\u2019s disease","volume":"55","author":"Olanow","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1124\/mol.107.035998_REF25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","article-title":"Smoking, nicotine and Parkinson\u2019s disease","volume":"27","author":"Quik","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.107.035998_REF26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1471-4159.2004.02177.x","article-title":"Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson\u2019s disease striatum","volume":"88","author":"Quik","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.035998_REF27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.105.094375","article-title":"Striatal {alpha}6* nicotinic acetylcholine receptors: potential targets for Parkinson\u2019s disease therapy","volume":"316","author":"Quik","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035998_REF28","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(02)00106-9","article-title":"Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage","volume":"112","author":"Quik","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/mol.107.035998_REF30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.104.006015","article-title":"Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA","volume":"67","author":"Quik","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF32","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1523\/JNEUROSCI.20-17-06431.2000","article-title":"Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse","volume":"20","author":"Ross","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neuropharm.2004.12.011","article-title":"The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay","volume":"48","author":"Salminen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.107.035998_REF35","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1124\/mol.107.035998_REF36","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.107.035998_REF37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0026-895X(24)26500-7","article-title":"125I-\u03b1-Conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain","volume":"57","author":"Whiteaker","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035998_REF38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.22-07-02522.2002","article-title":"Involvement of the alpha3 subunit in central nicotinic binding populations","volume":"22","author":"Whiteaker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.035998_REF39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2004.12.002","article-title":"Nicotine: from molecular mechanisms to behaviour","volume":"5","author":"Wonnacott","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/mol.107.035998_REF40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","article-title":"Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics","volume":"26","author":"Zecca","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.107.035998_REF41","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24044894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24044894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.035998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:53:08Z","timestamp":1739965988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24044894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0026895X24044894"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.035998","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nigrostriatal Damage Preferentially Decreases a Subpopulation of \u03b16\u03b22* nAChRs in Mouse, Monkey, and Parkinson\u2019s Disease Striatum","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.035998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}